All News

Some large wave and tidal projects are now coming to fruition, but they will need to secure a premium price for the electricity they generate.

The UK government has moved to promote the wider adoption of non-fossil fuels with a new action plan to unlock the potential for renewable energy in biomass.

Searching for the best tax incentives in European R&D? Then look no further than the Science|Business guide to this popular - though by no means universal - stimulant.

Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.

The review of intellectual property rights in the UK have created some strange allies.

Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.

Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.

While US companies have halted research into plant-made pharmaceuticals - or even gone bust - European companies are pressing ahead

The Finnish developers of a virtual guitar are looking for investment to develop the technology and to bring it to public venues.

Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.

A new journal might be worth watching, if you don't mind tearing down barriers between disciplines.

A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer

Big money is going into Europe's nanotechnology. This one has an interesting partnership between research and industry.

Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.

The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.